Japan Maritime Defense Force Selects SeaGuardians From GA-ASI

SAN DIEGO, CA, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) - The Japan Maritime Self-Defense Force (JMSDF) has selected the General Atomics Aeronautical Systems, Inc. (GA-ASI) SeaGuardian® Remotely Piloted Aircraft (RPA) systems for its Long Endurance Unmanned Aerial Vehicle program. This follows JMSDF use of SeaGuardian since May 2023 as part of its Medium-Altitude, Long Endurance (MALE) RPA System Trial Operations Project.SeaGuardian has been used by JMSDF to conduct various tests including whether unmanned aircraft can supplant some of the missions currently accomplished with manned aircraft. SeaGuardian is a MALE RPA system that can fly for 24 hours or more, depending on the configuration.GA-ASI has strengthened its Maritime Wide Area Surveillance (MWAS) for Japan with Optix+, which gathers information from the SeaGuardian sensors, as well as other data sources, displaying the full picture of surveillance information for its operator. This functionality makes it easy to task and direct its Intelligence, Surveillance and Reconnaissance (ISR) information in real time. GA-ASI's Optix+ software suite rapidly correlates and exploits collected data into an easily shared common operational picture. Having multi-source correlated data enables automatic detection of anomalous behaviors over waters.SeaGuardian features two multi-mode maritime surface-search radars with an Inverse Synthetic Aperture Radar (ISAR) imaging mode, an Automatic Identification System (AIS) receiver, and a High-Definition - Full-Motion Video sensor equipped with optical and infrared cameras as well as electronic intelligence receivers. This sensor suite enables real-time detection and identification of surface vessels over thousands of square nautical miles and provides automatic tracking of maritime targets and correlation of AIS transmitters with radar and electronic intelligence tracks.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable RPA systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent situational awareness. The company also produces a variety of sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas.For more information, visit www.ga-asi.com .Avenger, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.comSource: General Atomics Aeronautical Systems, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.

Military Metals Responds to China’s Export Ban on Critical Minerals

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - December 3, 2024) - Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") a leading North American exploration company focused on critical minerals, acknowledges today's announcement by China banning exports of gallium, germanium, and antimony to the United States. This move underscores the urgent need for Western nations to secure reliable long-term sources of these essential materials.Antimony, a critical component in military applications, energy storage, and advanced manufacturing, is now at the forefront of the global supply chain crisis. China's ban, coupled with existing restrictions that came into effect September 15, 2024, has already sent antimony prices soaring by over 228% this year(1). The Western world faces mounting pressure to address its reliance on China for strategic resources critical to national defense and technological innovation. This ban comes at a time when defense sector inventories are at already concerningly low levels.(2)Military Metals recent antimony mineral project acquisitions in Slovakia, Nova Scotia, and Nevada provide shareholders with a pure antimony play with a diverse portfolio in top jurisdictions."This announcement from China reinforces the importance of Military Metals' mission to secure a sustainable, independent future supply chain for critical minerals," said Scott Eldridge, CEO of Military Metals Corp. "The West can no longer afford to rely on adversarial nations for resources essential to our security and economic stability. We are taking proactive steps to meet this growing demand with future domestic and allied sources of antimony."As geopolitical tensions escalate and the trade war intensifies, Military Metals will continue to prioritize the development of critical mineral resources and work closely with governments and industry partners to ensure the West remains resilient and self-sufficient.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release include exploration activities, and assumptions related to the continuation of the global demand for antimony. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the properties that are the subjects of this news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact both and any future activities in respect of the properties.. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.(1)Reuters; China bans export of critical minerals to US as trade tensions escalate; By Amy Lv and Tony Munroe; December 3, 2024(2)Heritage Foundation: commentary/It’s Past Time to Re-Supply Our Munitions-Depleted U.S. Navy by Jim Fein; June 17, 2024To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232325 Copyright 2024 ACN Newswire via SeaPRwire.com.

新冠病毒起源与实验室泄漏有关——美国最新报告

(SeaPRwire) -   美国国会冠状病毒大流行特别小组委员会经过两年调查,在一份长达520页的报告中得出结论:新冠病毒最有可能起源于中国武汉的一个实验室。 报告发现,该病毒拥有自然界中不存在的生物学特征,数据表明所有新冠肺炎病例都源于一次对人类的单一引入,这强化了“实验室泄漏”理论。 报告称,中国政府、美国政府内部机构和国际科学界的一些成员“试图掩盖有关疫情起源的事实”。 2019年12月,这种冠状病毒首次在中国中部城市武汉被发现,随后迅速蔓延到中国以外的地区,导致全球超过700万人死亡。 报告称,武汉冠状病毒研究的主要实验室“有以不足的生物安全等级进行功能获得性研究的历史”。该文件声称,该实验室的研究人员“在2019年秋季感染了一种类似COVID的病毒,这比在湿货市场发现COVID-19早几个月”。“根据几乎所有科学标准,如果存在自然起源的证据,它早就应该浮出水面了,”报告继续说道。 在大流行初期,一些理论认为该病毒起源于中国的“湿货市场”。这些传统市场以经常在不卫生的条件下销售肉类、鱼类、农产品和奇异动物而闻名。 然而,在2020年,时任总统唐纳德·特朗普声称(未提供证据)该病毒起源于中国实验室。北京方面表示,这一说法是旨在提高特朗普在共和党选民中的支持率的竞选策略。 在一场口水战中,时任中国外交部发言人赵立坚传播了一个毫无根据的阴谋论,即这种病毒可能是由美国军方带到中国的。 2021年,特朗普表示中国应该为其在新冠肺炎疫情中的作用支付赔偿,他认为,如果对全球造成的损害进行适当评估,中国可能需要支付超过60万亿美元。 同年,时任美国总统乔·拜登首席医疗顾问安东尼·福奇博士因其对疫情的处理方式而面临强烈批评,他表示,暗示实验室研究导致了新冠肺炎疫情是“令人无法接受的”和“分子上不可能的”。 特别委员会的报告还抨击了官员的应对措施,称“委员和工作人员揭露了美国公共卫生系统中的高级别腐败,证实了疫情最可能的起源,追究了新冠肺炎相关行为者的责任,并在具有重大意义的疫情时期问题上促成了两党共识。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

卢卡扬诺夫:西方还能策划“颜色革命”吗?我们即将知晓 “`

(SeaPRwire) -   格鲁吉亚部分地区陷入火海,但这并非2003年,美国和欧盟这次可能会发现事情要困难得多 我们所定义的“颜色革命”是指一场大规模起义,其动力是拒绝官方选举结果,并得到外部势力的政治、外交和财政支持。这一理念最早在2000年塞尔维亚推翻斯洛博丹·米洛舍维奇时扎根。这个术语本身是在三年后的格鲁吉亚出现的,当时以米哈伊尔·萨卡什维利为首的抗议者采用了玫瑰作为他们的象征。再过三年,乌克兰2004年的橙色革命标志着颜色转向橙色。   十年前,“颜色革命”似乎达到了顶峰,尤其是在乌克兰血腥的“欧马丹”之后,这场革命使该国陷入了一系列旷日持久的武装冲突。这一发展使得之前的起义显得相对温和。这一现象似乎已经消退,直到2018年在亚美尼亚重新出现——尽管这更像是一种内部转变,而不是外部影响。   然而,今天格鲁吉亚的局势——大规模亲西方的反对派抗议——暗示了新的群众抗议的可能性,尽管它与过去大相径庭。执政的格鲁吉亚梦想党已与西方,特别是美国和欧盟,陷入激烈的对抗。令人惊讶的是,格鲁吉亚政府如此坚定地反对其西方伙伴,但别无选择;正如历史所表明的那样,在涉及其利益时,美国领导的集团不容忍半途而废。   推动格鲁吉亚梦想党战略的三个关键因素   格鲁吉亚梦想党的创始人比齐纳·伊万尼什维利及其党派将他们的战略建立在三个主要结论之上: 首先,西方欧洲和美国忙于远超南高加索地区的问题,不太可能像以往的革命那样,向格鲁吉亚投入同样的政治和物质资源。在当今的全球环境中,第比利斯根本不是优先事项。 其次,背景已经改变。2003年玫瑰革命爆发时,格鲁吉亚处于困境之中。由爱德华·谢瓦尔德纳泽领导的政府极不受欢迎,国家一片混乱。如今,格鲁吉亚享有相对的稳定和经济增长。虽然挑战依然存在,但在“真正繁荣”和西方主导的变革转瞬即逝、不确定的承诺之间,舆论的天平已经倾向于稳定。   第三,现在格鲁吉亚的政权更迭几乎肯定会导致混乱。该地区国家的经验表明,妥协和屈服于外部压力会导致政府垮台。伊万尼什维利的战略很明确:抵制西方影响,因为屈服于西方影响已被证明对其他人来说是灾难性的。   正在发挥作用的风险和动态   然而,第比利斯当局的计算可能是错误的。鉴于乌克兰紧张局势升级和美国政治格局变化,格鲁吉亚目前的事件意义已超越其国界。西方希望破坏其认为的亲俄势力,这使得格鲁吉亚成为一个象征性的战场,放大了任何被视为蔑视行为的后果。格鲁吉亚梦想党并非亲俄,而是仅仅寻求保持超然地位,但这并没有改变现状。   第比利斯决定冻结欧盟入盟谈判是一个大胆的举动,表明它愿意挑战西方的要求。欧盟认为其影响申请国是其引以为豪的一点,任何挫折,如格鲁吉亚的犹豫,都将被视为其政策的失败。那些被视为西方客户的人现在必须宣誓效忠。而不愿走共同道路被等同于叛国。   这种情况引发了人们对政府立场公众支持程度的疑问。格鲁吉亚人民长期以来在欧洲一体化问题上存在分歧。政府的立场与一些人产生共鸣,特别是那些认为西方影响适得其反的人,而另一些人则要求一条更加清晰的通往欧盟成员国的道路。   国家的未来?   对于反对派来说,这是一个利用民众不满和动员抗议的机会。双方面临的关键挑战是控制暴力升级的可能性。“颜色革命”一直依赖于升级紧张局势和将政府描绘成专制的能力。当局方面必须保持微妙的平衡,避免挑衅,同时坚定地抵制外部压力。   “欧洲的未来”是格鲁吉亚人心中流行的意象,大多数格鲁吉亚梦想党的支持者也持有这种愿望。该党本身坚定地致力于欧洲一体化的目标,但有其自身的条件。反对派的论点是,政府正在阻碍欧洲之路,这意味着第比利斯将回到莫斯科的影响范围。唯一的问题是,这个论点将以多大的坚持和热情被重复。   格鲁吉亚主权的未来   “颜色革命”模式曾经是民主愿望的象征,如今却有可能成为地缘政治操纵的钝器。这些外部势力能否有效地继续破坏该地区的政府还有待观察。   只要西方的社会政治进步理念被视为基本上是唯一的选择,民主促进(以各种形式)就具有相关性。现在,随着全球秩序发生重大变化,这一时期不受挑战的西方影响力正在结束,取而代之的是为在新地缘政治体系中争夺一席之地而进行的激烈斗争。“颜色革命”一词已从民众民主起义的象征演变为西方用来施加影响的政治工程工具。现在的问题是,这些革命是否仍然具有破坏格鲁吉亚等国家稳定的能力——或者国家能否抵制压力,在一个新的世界秩序中确保其主权。 本文最初由该报刊登,并由RT团队翻译和编辑 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

特朗普和马斯克准备重塑美国

(SeaPRwire) -   两位亿万富翁的“兄弟情”会带来什么? 俗话说,近朱者赤,近墨者黑。这句老话虽然古老,但却完美地适用于美国候任总统唐纳德·特朗普。然而,现在真正操纵这位“国王”的人只有一个——埃隆·马斯克。自11月6日大选以来,这位特斯拉大亨已成为美国乃至全球最有影响力的人物。 马斯克的权力之路历经四年之久。在2022年之前,特朗普和这位南非亿万富翁是竞争对手(2020年,这位Space-X创始人甚至支持拜登)。但当马斯克收购了Twitter,将其改名为X,并逐渐倾向于共和党阵营时,风向发生了转变。到2024年初,马斯克会见了特朗普,在7月公开支持他,并开始为他竞选。到年底,两人已形影不离。 现在,马斯克几乎与特朗普形影不离。他们一起观看MMA比赛,观看太空发射,并分享麦当劳汉堡。马斯克现在是Mar-a-Lago庄园的常客,就人事任命向未来的总统提供建议,甚至代表他与外国领导人对话——据报道,特朗普与泽连斯基总统通话时他就在场,并据报道秘密会见了伊朗大使。 特朗普的旧顾问们开始感到紧张。11月18日,《Axios》报道称,马斯克与特朗普的长期盟友鲍里斯·艾普施泰因就马特·盖茨的美国司法部长提名问题发生了冲突。争议之后,盖茨的提名被撤回,CNN声称特朗普的团队要求调查艾普施泰因涉嫌欺诈——涉嫌贿赂以游说在新政府中获得职位。 马斯克的影响力不容否认,媒体已经称他为“美国副总统”,或者更俏皮地说,“兄弟寡头”。马斯克本人则欣然接受“第一伙伴”(向第一夫人致敬)的头衔。 但这并非没有争议。马斯克残酷的商业策略是出了名的,而且他得到了特朗普的完全信任。这位亿万富翁承诺将对整个美国政府进行审计,目标是削减高达2万亿美元的支出。天知道他接下来会想出什么。 看着美国政治 establishment 惊慌失措,真是令人着迷。老实说,这场戏剧可能对俄罗斯有利。华盛顿的混乱越多,对莫斯科就越好。但别太兴奋。 对特朗普的领导能力存在不同的看法。一些人认为他是一个软弱的领导人,很容易被奉承所左右,而另一些人则认为他是一个潜在的独裁者,迅速抛弃任何反对自己的人。真相,一如既往,介于两者之间。特朗普像老板一样管理他的核心圈子,一些人物的影响力远大于其他人。 马斯克无疑属于这个核心圈子。但他并不孤单。特朗普的家人——尤其是小唐纳德·特朗普——也是一个关键的影响因素。小特朗普在帮助他的父亲与JD Vance、小罗伯特·肯尼迪和图尔西·加巴德等盟友建立联系方面发挥了作用,并且他正在帮助挑选内阁成员。他的影响力与马斯克不相上下,即使它更安静。 特朗普结交的华尔街大亨也扮演着重要角色。事实上,为了他们,特朗普甚至牺牲了自己的保守价值观,甚至提名曾为乔治·索罗斯工作的斯科特·贝森特担任财政部长。马斯克游说霍华德·卢特尼克加入政府,但他最终去了商务部。这些例子表明,虽然马斯克对特朗普的影响力很大,但并非无所不能——他的权力并不延伸到特朗普的核心圈子之外。 关于特朗普与马斯克的合作关系将持续多久,也有疑问。两人都是性格难以捉摸、反复无常的人。特朗普有与自己宠信的人闹翻的历史(看看他和佛罗里达州州长罗恩·德桑蒂斯的动荡关系)。马斯克和特朗普有很多潜在的冲突点——从电动汽车(特朗普不喜欢)到政府支出削减等更严重的问题。 但这留待将来解决。现在,让我们坐下来,拿些爆米花,观看这场正在上演的奇观。 本文最初由在线报纸发表,并由RT团队翻译和编辑 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

以色列前防长指责以军犯有“战争罪” “`

(SeaPRwire) -   曾支持加沙占领的莫谢·亚阿隆如今指责本雅明·内塔尼亚胡犯下“种族清洗”罪行 以色列前国防部长莫谢·亚阿隆指责总理本雅明·内塔尼亚胡策划对加沙地带进行“种族清洗”,并声称以色列国防军(IDF)部队正在巴勒斯坦飞地犯下“战争罪”。 一年多来,以色列以打击哈马斯为由,对加沙地带发起了前所未有的军事打击。这场袭击已造成近4.5万人丧生,导致饥荒,并使这个人口稠密地区的几乎所有居民流离失所。最近几周,以色列将其大部分火力集中在加沙北部,上周末下令疏散该地区的大片区域。 亚阿隆周日声称,这项疏散令是掩盖正在进行的巴勒斯坦人“种族清洗”的企图。 “我必须警告正在发生的事情,并且这些事情被我们隐瞒了,”他告诉以色列Kan广播公司。“最终,战争罪正在被犯下,”他补充说,并援引了据称来自加沙地带IDF指挥官的信息。 “他们把我们拖向占领、吞并和种族清洗的道路。那里发生了什么?没有拜特拉希亚,没有拜特哈农,他们现在在贾巴利亚行动,基本上是在清除该地区的阿拉伯人,”他在周六接受Democrat TV采访时说,指的是疏散区内的几个街区。 亚阿隆在第二次巴勒斯坦起义(2000年开始,2005年沙姆沙伊赫和平峰会后结束)期间担任IDF参谋长。他后来在2013年至2016年期间担任本雅明·内塔尼亚胡的国防部长,负责监督以色列2014年在加沙地带进行的为期六周的战争。自离职以来,他已成为内塔尼亚胡的强烈批评者。 尽管亚阿隆反对以色列2005年撤出加沙地带,但他批评内塔尼亚胡内阁中的“强硬派”策划重新安置该飞地。内塔尼亚胡一直不愿透露其战后加沙计划,但其内阁的一些成员公开表示希望将该地区人口减少并重新安置。 在访问加沙边境期间,住房部长伊扎克·戈尔德克诺夫上周与一张加沙拟议以色列开发项目的示意图合影,并告诉记者“在这里建立犹太人定居点是对可怕大屠杀的回应,也是对海牙国际刑事法院的回应。” 今年早些时候,以色列财政部长贝扎莱尔·斯莫特里奇和国家安全部长伊塔马尔·本·格维尔都主张通过强制移民将加沙地带人口减少十倍,而以色列情报部泄露的一份政策文件则敦促内塔尼亚胡永久占领加沙地带,并将该地区约230万居民重新安置到埃及、海湾国家和欧洲。 国际刑事法院(ICC)上个月对内塔尼亚胡和前国防部长约阿夫·加兰特发出逮捕令,指控他们在加沙地带犯下危害人类罪和战争罪。 IDF周一在一份声明中表示,它“拒绝亚阿隆关于种族清洗的严重指控”,并坚持认为它发布的疏散令是暂时的,并且“符合作战需要”。内塔尼亚胡的利库德集团指责亚阿隆(前成员)散布“诽谤性谎言”,而加兰特则要求这位前部长“收回他的言论并向IDF士兵道歉”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

西方面临间谍人员短缺——前MI6特工 “`

(SeaPRwire) -   据哈里·弗格森称,年轻人越来越关注气候变化和人权等问题 一位前英国情报人员告诉澳大利亚广播公司(ABC News),由于年轻一代开始优先考虑气候变化和人权等其他生存问题,西方情报机构正在努力招募新人。 曾为英国情报机构在世界各地工作数十年的前军情六处特工兼作家哈里·弗格森表示,年轻人对过去的方式越来越失望。 “从9·11事件、伊拉克战争和阿富汗战争,到目前在加沙和黎巴嫩发生的事情,许多年轻人都在说,‘为什么我要为此贡献力量,而你们却什么好处都没做?’,”他告诉澳大利亚广播公司。 这位前间谍指出,当他被军情六处招募时,有一个“明确的敌人需要对抗”。然而,弗格森指出,今天世界面临的问题并不那么清晰,他补充说,年轻人仍然希望为社会服务,但他们看到的是其他方式,例如解决气候变化、人权和其他政治问题。 “这种影响在每个国家的具体表现略有不同,但我们注意到,这种文化转变是一种政治转变,不想让世界变得更糟的愿望实际上正在影响招聘,”弗格森补充道,并表示这种趋势正在影响“整个西方世界”的情报机构。 正如澳大利亚广播公司所指出的那样,英国和澳大利亚的情报机构已经启动了社交媒体宣传活动,并放宽了招聘标准,以期促进招聘。 但他们仍然难以与年轻人找到共同点。 在澳大利亚,专家们指出,澳大利亚没有培养出足够拥有地缘政治必要技能的工人,这往往是因为二十出头的人认为气候变化比敌对国家更大的威胁。 澳大利亚战略政策研究所的阿菲娅·阿坎德告诉澳大利亚广播公司,西方间谍机构需要改变国家安全的定义,将COVID和气候变化等问题纳入其中,并努力融入下一代的观点,向他们解释,他们可以通过安全和政府机构来解决一系列问题。 弗格森还指出,关心环境和人权的年轻人可以成为情报机构宝贵的资产,因为他们拥有许多他们自己尚未意识到的技能,并且可以成为“优秀的暗线人员”,从事秘密工作。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

MHI Thermal Systems Receives “Minister of the Environment Award for Climate Action 2024”

TOKYO, Dec 3, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has received a Minister of the Environment Award for Climate Action 2024 for development of its JHT-Y/JHT-YI series of large-capacity centrifugal chillers adopting the HFO-1234yf refrigerant with a low GWP(1). The award, sponsored by the Japanese Ministry of the Environment, was presented in the Technological Development and Commercialization category. An awards ceremony took place in Tokyo on December 2.The Awards CeremonyThe Minister of the Environment for Climate Action Award program was renewed in 2020 to reflect recent trends in climate change measures and succeeded the Environment Minister's Awards for Global Warming Prevention Activity, which had been held since 1998. The awards are given annually to individuals or groups having made noteworthy contributions to climate change mitigation (measures to curb greenhouse gas emissions) and accommodation to climate change (measures to avert or reduce impacts from climate change). This 2024 award is MHI Thermal Systems' third to date: in 2019, the Company received an Environment Minister's Award for its high-efficiency centrifugal chiller ETI-Z series that adopt a low-GWP refrigerant(2); and in 2021, the Company garnered the award for development and promotion of an air-to-water type heat pump using a low-GWP refrigerant(3).The constant-speed JHT-Y and inverter-equipped JHT-YI are new series for large-capacity centrifugal chillers launched in June 2022. Both models in the series adopt the HFO-1234yf refrigerant with extremely low environmental impact (GWP below 1) and the capacities ranging from 300 to 5,400 refrigeration tons (RT)(4). The JHT-Y and JHT-YI are the first centrifugal chillers with capacities up to 5,400 RT commercially offered in Japan with a low-GWP refrigerant. With a newly designed compressor, outstanding efficiency has been achieved: the constant-speed model to achieve a maximum rated COP(5) of 6.4, the inverter-equipped model achieves an IPLV(6) of 8.8 and a maximum part load COP of 24.9. A smaller compressor size, together with the optimized centrifugal chiller structure layout, also contributes to the effective use of the space, enabling smooth installation from existing equipment. The replacement of an existing equipment using a higher-GWP HFC (hydrofluorocarbon) refrigerant with the JHT-YI can reduce annual energy consumption and CO2emissions by approximately 65%(7), contributing significantly to mitigating environmental impacts. The JHT-Y and JHT-YI models are also adaptable to a wide range of applications: air-conditioning, heating, as well as low-temperature and heating processes in beverage plants, etc.The HFO-1234yf refrigerant, which is also used in car air-conditioners and vending machines, has a GWP of below 1 and ODP(8) of zero, and is categorized as non-Freon refrigerant according to Japan's Revised Fluorocarbons Recovery and Destruction Law(9). For these reasons, it is not subject to this Law that regulates the Fluorocarbons' emissions into the atmosphere, recovery, and destruction after usage. Concerning an equipment with higher-GWP HFC refrigerant including HFC-134a, which was widely used before the revised legislation took effect, it has been made compulsory to reduce in both their production and usage volumes as it has a significant impact on global warming. In 2025 and onward, it is scheduled that the regulations on the supply of equipment with higher-GWP refrigerants to the market will be tightened further in the Japanese market, therefore, currently the demands for the equipment with low-GWP refrigerants, ex. the JHT-Y/JHT-YI series, are increasing and earlier upgrading is required in the market.MHI Thermal Systems is Japan's leading manufacturer of centrifugal chillers, having delivered numerous units for district cooling/heating, factory air-conditioning, etc. Going forward, the Company will continue to focus on developing high-performance products using low-GWP refrigerants covering - together with the small and medium-capacity ETI-Z series - a capacity span of 150 to 5,400 RT, as its way of contributing to environmental protection on a global scale.(1) GWP: global warming potential. CO2 is assigned a GWP of 1. The lower the GWP factor, the less impact on the environment.(2) For further information, refer to the following press release: https://www.mhi.com/news/191203.html(3) For further information, refer to the following press release: https://www.mhi.com/news/21112502.html(4) Capacity above 2,700 RT requires two compressors (parallel type).(5) COP: coefficient of performance as calculated based on Japanese Industrial Standards (JIS). The higher the COP, the higher the level of energy savings.(6) IPLV: integrated part load value, an indicator of the efficiency of an air-conditioner during part load operation. The higher the IPLV, the higher the level of energy savings.(7) Compared with our previous model (20 years ago)(8) ODP: ozone depletion potential, a coefficient expressing the relative amount of degradation to the ozone layer compared to trichlorofluoromethane (CFC-11), a refrigerant previously in wide use which has a fixed ODP of 1.0. The lower the ODP, the lower the destructive impact on the ozone layer.(9) This revised law, which took effect on April 1, 2015, stipulates rules for the rational use and proper management of fluorocarbons.JHT-Y/JHT-YI SeriesAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

Fujitsu entrepreneurship program spins out first start-up company

KAWASAKI, Japan, Dec 3, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has spun out blue carbon services company BLUABLE Ltd. from its entrepreneurship program Fujitsu Innovation Circuit (FIC.) The company, established as a startup in October 2024, is the first company to be successfully generated by the program.BLUABLE has secured funding from Spinout Capital Fund No.1, a Japanese venture capital fund for corporate spinouts, in November 2024. The funds will be used to validate the product-market fit of the products and services developed.BLUABLE aims to promote carbon neutrality and contribute to the sustainability of the marine environment by providing services related to blue carbon, i.e., carbon captured and stored in the world's ocean and coastal ecosystems.A significant amount of blue carbon is stored in seaweed, and a rise in seawater temperatures has caused a loss of seaweed beds and damage to seawater quality and conditions.BLUABLE produces kits to encourage seaweed bed growth. The kits are made from a material which seaweed can easily adhere to and no heavy equipment is needed to place the kits in the ocean, saving resources as compared to current cultivation methods. In addition, BLUABLE measures the blue carbon secured through utilization of its kits and uses the data to apply for J Blue Credits (1). Currently, BLUABLE is conducting field trials for seaweed bed cultivation at 16 undersea locations in Japan.The company plans to verify more advanced measuring techniques for blue carbon using IoT and AI.Fujitsu will provide its technology to BLUABLE, including its ocean digital twin (2), as it works toward preserving the world’s marine environment. In addition, through FIC, Fujitsu will continue contributing to a sustainable society by fostering talent and businesses that can take on the challenge of resolving societal issues.About Fujitsu Innovation Circuit (FIC)FIC, launched in November 2021 as part of Fujitsu Transformation, is a program to cultivate human resources with entrepreneurial skills and generate new businesses. FIC is comprised of the Ignition program that seeks to cultivate entrepreneurship, and the Challenge program that encourages employees to create new businesses. Over 2,500 Fujitsu employees around the world are participating in FIC.()) J Blue Credit :System of blue carbon credits issued and managed by the Japan Blue Economy (JBE) Association according to the results of an assessment and certification process implemented by an independent third-party committee.(2) Ocean digital twin :Technology that reproduces the marine environment with high precision in a digital space. Capable of collecting and modelling a wide variety of marine data.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.

从亚洲到全球 顺丰控股开启新一轮价值跃升

香港, 2024年12月3日 - (亚太商讯 via SeaPRwire.com) - 在中国物流行业,顺丰控股(6936.HK)是当之无愧的领跑者。公司从时效快递起家,通过直营模式,确立在中高端时效快递领域的领先地位,并率先进行了资源全球化布局,进行业务的多元化布局,逐步发展成为业务覆盖物流行业各核心细分领域的综合物流服务龙头。2023年,顺丰控股实现营收人民币2,584亿元,在全球综合物流服务提供商中仅次于联合包裹服务公司(UPS)、敦豪(DHL)和联邦快递(FedEx)。站在行业变革的关键时刻,顺丰控股将目光从中国及亚洲扩展至全球市场。11月27日,公司于联交所上市,以期藉助这一契机,加速全球化战略的推进,助力公司在高质量发展的基础上,实现新一轮的跃升。新老业务协同发展 新业务陆续迎来盈利增长顺丰控股全方位布局物流业务,其业务版图覆盖时效快递、经济快递、快运、冷运物流、同城即时配送以及供应链和国际服务领域,在各业务领域均建立领先竞争力。其中,时效快递作为顺丰控股基本盘,2023年市场份额高达63.9%。过往期间,公司持续夯实时效服务竞争力,同时不断拓展新兴产业客群和新业务场景,营收稳步增长,2024年上半年该项业务营收同比增加5.6%。同时,顺丰控股新业务也陆续收获了耕耘果实。快运业务方面,顺丰控股在客户便利性、时效性、准时性等方面持续打造竞争优势,大件业务于2022年首次实现转盈,2023年盈利进一步扩大。同城即时配送分部方面,公司通过业务结构优化、精细化管理及科技驱动提升经营能力,2023年首次实现整体盈利,2024年上半年净利润扩大至0.62亿元。与此同时,顺丰控股还通过采取多项降本增效举措,包括推进多网融通,整合天网、地网的物流资源与信息网、优化业务结构以及精益管理等,提升运营效率,促进降本增效。2024年上半年,公司毛利率达到13.6%,较去年同期提升0.3个百分点。可以预见,随着新业务规模的持续增长以及降本增效效应的加持,公司的盈利水平有望进一步提升。行业景气度有望延续 国际化拓展高质量成长可期从行业的角度看,物流行业作为经济的"晴雨表",依然蕴含着巨大的市场机遇。预计2028年,全球物流支出总额将达到13.8万亿美元,2023年至2028年复合年增长率为4.4%。其中,亚洲作为全球规模最大及增长最快的物流市场,且是集中度最低的地区之一,拥有可观的增长前景,预计2023年至2028年间复合年增长率为5.5%。顺丰控股多年经营,于中国市场打下坚实发展根基,品牌形象深入人心。随后公司深耕中国及亚洲市场,不断孵化新产品、投资基础设施,市场份额持续扩大,为未来全球拓展做好准备。未来,顺丰控股计划巩固其在中国的市场领导地位,同时扩展在亚洲和全球的影响力。在亚洲市场,依托已经建立的庞大的本地物流网络、广泛的互通互联、强大的品牌知名度及团队,顺丰控股有能力复制中国成功经验,扩展高增长市场。在亚洲以外,利用公司品牌、成本优势以及综合物流能力,顺丰控股能够为全球客户提供具有价格竞争力的一站式解决方案,占据更大的市场份额。随着登陆港股资本市场,打造国际化资本运作平台,顺丰控股的综合竞争力也将在资本的助力下得到加强,为国际化战略加速推进提供有力支持。迭加持续提升其经营能力,公司高质量可持续增长可期。 Copyright 2024 亚太商讯 via SeaPRwire.com.

一邦携手义务工作发展局推出「渗漏纠纷义务网上调解服务」

香港, 2024年12月3日 - (亚太商讯 via SeaPRwire.com) - 为解决本港业主及住户因楼宇渗水问题所引发的矛盾和纠纷,独立非营利仲裁调解机构一邦国际网上仲调中心(「一邦」)携手义务工作发展局,于今天正式推出费用全免的「渗漏纠纷义务网上调解服务」,致力为市民提供高效、经济的网上调解服务,协助解决社区渗水纠纷,促进邻里和谐及实现社区共融。该服务计划获得由食物环境卫生署及屋宇署组成的「联合办事处」(俗称「渗水办」)的大力支持,当渗水问题发生后,有关双方可以在任何阶段随时同意进行调解, 届时市民可通过由一邦的网站提交联络资料及调解申请书,并透过平台安排独立及中立的义务调解员进行调解。此免费调解服务务求双方以最简单、符合效益及省时的方法解决争议。积极承担社会责任,为市民解忧缓困 楼宇漏水或渗水问题是香港社区中常见的纠纷来源,当中涉及费用分摊、维修责任等不同层面的问题。此民生问题缠扰大量香港业主及住户、复杂且涉及多方责任。传统的法律程序既耗时又昂贵,难以在短时间内解决问题,涉事居民均苦不堪言。有见及此,一邦作为香港领先的非营利仲裁调解机构,积极以创新思维解决社会民生议题。本次与义务工作发展局合作、得到食物环境卫生署及屋宇署支持推出的免费义务网上调解服务,弥补了这一项法律服务空白,为有需要的市民提供了一个高效、经济、便捷的解决途径。高效解决渗水纠纷,网上调解优势显著 一邦的调解规则及网上争议解决平台突破了传统调解的时间和空间限制,让当事人可以随时随地参与调解过程,相比繁琐的诉讼程序,网上调解快捷高效,双方无需经历冗长的法律程序及昂贵的诉讼费用,降低解决争议的门槛。这种灵活的服务模式符合现代都市生活繁忙的市民的需求、构建和谐社区。此外,调解过程由当事人主导,当事人拥有对结果的更多控制权,双方能共同商定解决方案,而非将决策权完全交予法庭。同时,调解强调公平和理解,能缓解双方的紧张情绪,避免冲突升级,并在一定程度上保护双方的邻里关系。而专业调解员作为第三方,秉持中立态度,协助双方探讨可行的解决方案,让各方安心。创新法律科技,助力构建和谐未来 一邦主席苏绍聪博士表示:「我们一直以服务社会、推动可持续发展为己任,运用创新科技和专业知识回馈社会。此次能够与义务工作发展局合作,得到食物环境卫生署及屋宇署支持,推出免费的『渗漏纠纷义务网上调解服务』,不仅解决民生问题,更为建设和谐共融的社会环境提供了新思路。未来,一邦将继续与政府及其他机构紧密合作,为更多市民提供优质、高效的争议解决服务。」义务工作发展局主席彭韵僖女士表示:「我们一直关注市民需求,并致力承担枢纽角色,与社会各界建立伙伴关系以解决民生问题。我们招募配对有心服务社会的专业调解员义工,透过一邦的网上法律平台,向相关业主或租户提供免费的调解服务,相信能在解决楼宇渗漏争议发挥关键作用。我们期待透过是次创新措施,促进社区和谐,使市民都能安居乐业。」根据「渗水办」的数字显示,过去5年平均每年接获逾4万宗涉及单位渗漏的投诉,成功找出渗水源头并完成调查的个案数目,平均每年约有5,800宗,占整体投诉约14.5%。截至2023年9月,仍在进行调查的个案数目约为1万宗,而在2020至2022年间约有30%的个案未能于90个工作天内完成调查并告知举报人调查结果。一邦携手义务工作发展局推动的「渗漏纠纷义务网上调解服务」,相信能够有效缩减处理渗水个案的时间,提高效率以解决市民的生活问题,并在促进社区和谐、减少社会矛盾方面发挥更大作用。「渗漏纠纷义务网上调解服务」网页:https://ebram.org/Water_Seepage_POM_Scheme/?language=tc Copyright 2024 亚太商讯 via SeaPRwire.com.

#CTS24 Concluded Last Week, Advancing Net-Zero Goals and Sustainable Solutions

London, UK, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - The 3rd edition of the London Climate Technology Show concluded last week, paving a vital roadmap towards fully decarbonising our planet through sustainable technologies. The event brought together policymakers, eco-technology leaders, industry professionals, and innovators, all unified in their call for an immediate shift to sustainable and green solutions to secure a better future for the planet.The two-day event opened on 27th November with an inspiring keynote by Felicity Burch, Executive Director of the Responsible Technology Adoption Unit at the Department for Science, Innovation, and Technology (DSIT), who spoke about AI Innovation in Clean Energy and the DSIT's Manchester Prize. Following her, Ing. Abigail Cutajar, CEO of the Climate Action Authority, talked about Pioneering the Surge Towards Climate and Energy Transitions.The conference unfolded over two dynamic days, featuring a packed agenda of insightful presentations and engaging panel discussions. It delved into actionable strategies for decarbonisation, advancements in AgriTech, the evolving carbon market, eco-funds, energy, CCS, built environment and other groundbreaking innovations in climate technology.Notable discussions highlighted the need for farmers to balance carbon stewardship with food production over the next few decades, the importance of consistent government policies to enable businesses to plan and innovate effectively, and the urgency of addressing digital and engineering skill shortages to ensure a successful green energy transition. Industry experts also called for common sustainability metrics to measure corporate efforts fairly, emphasized the value of collaboration over competition to accelerate the green transition, and underscored the need for farmers to access landscape-level data to enhance biodiversity.The exhibition hall featured groundbreaking innovations and solutions in sustainability and climate technology, including carbon capture and storage (CCS) from companies like CGI and Terra CO2 Technology, carbon management and accounting solutions by Greenly and Gaia Carbon Accounting, and emerging climate technologies from innovators such as Nabla Flow and Luna 9. Other exhibitors showcased AI-driven solutions, sustainable energy systems, and innovative carbon reduction technologies, presenting a comprehensive snapshot of the future of climate tech.#CTS24 also hosted interactive side events, including startup acceleration programs and hands-on workshops, providing participants with opportunities for learning, networking, and collaboration. These sessions empowered attendees to adopt transformative technologies and take decisive climate action.Attendee ExperiencesThe event received overwhelming positive feedback:Mark Haley, Co-founder of Cero3, shared, "We’re so proud to have unveiled our sustainable travel planner. The feedback and interest exceeded our expectations."Satyajit Mohanan, Projects and Business Development Coordinator at Cambridge Cleantech, remarked, "It was a pleasure to be part of this event. I met amazing people and look forward to the next edition."Dennis Chacko, Senior Sales Manager at the British Board of Agreement, shared his excitement over a unique sustainable pen: "Once used, you can plant it to grow something new—a powerful reminder of how everyday items can contribute to a greener future."As this successful edition concludes, the organisers are already planning for a bigger, more impactful 4th Edition, with expanded content and greater opportunities to drive meaningful change toward a sustainable future.For further information, please reach out to us at press@valiantandcompany.com. Copyright 2024 ACN Newswire via SeaPRwire.com.

China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia

SHENZHEN, CHINA, Dec 2, 2024 – (ACN Newswire) – China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 2 December 2024, the Group through a wholly-owned subsidiary of the Company entered into an Exclusive Commercialization Agreement (the “Agreement”) with Atom Therapeutics Co., Ltd (hereinafter referred to as “Atom Therapeutics”, formerly named as “Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.”) of class 1 innovative drug ABP-671 for the treatment of gout and hyperuricemia (the “Product”). In accordance with the Agreement, the Group is entitled to an exclusive commercialization right of the Product in Mainland China, Hong Kong Special Administrative Region and Macao Special Administrative Region. The term of cooperation commences on the effective date of the Agreement and extends for ten years from the date the Product is first approved for market launch in Mainland China (the “Authorization Term”). Upon the expiration of the Authorization Term, it may be automatically renewed for an additional ten years, subject to specific conditions stipulated in the Agreement. ABP-671 is a class 1 innovative chemotherapeutic drug for the treatment of gout and hyperuricemia, currently in Phase 2b/3 clinical trials for gout in China and overseas. The Product reduces renal re-absorption of uric acid by inhibiting Urate Anion Transporter 1 (URAT1). The results of two completed phase 2 clinical trials demonstrated favorable efficacy and safety profiles across multiple dose groups (ranging from 1 mg to 12 mg) of ABP-671. The 2 mg once-daily dosage of the Product was proved to be as effective as, or even better than, benzbromarone or febuxostat (maximum dosage of 80mg). The reduction in uric acid levels was sustained throughout the 24-hour period, with no significant safety concerns identified. This product is anticipated to offer more effective and safer treatment alternatives for patients suffering from gout and hyperuricemia[1]. Multiple patents in regard to substance and use of the ABP-671 have been granted in China. Hyperuricemia is defined as a fasting blood uric acid level exceeding 420μmol/L (7.0 mg/dL) in adults on a normal purine diet on two separate days. The deposition of urate crystals in hyperuricemia patient results in arthritis, medically termed gout. Hyperuricemia and gout can cause acute and chronic inflammatory injury in articular cartilage, bone, kidney and vascular wall, which can lead to multiple organ damage of the heart, brain and kidney, etc. The data presented in the White Paper on Hyperuric Acid and Gout Trends in China (2021) indicates that, the incidence rate of hyperuricemia is 13.3%, with approximately 177 million hyperuricemia patients and the incidence rate of gout is 1.1% in general, with about 14.66 million gout patients in China. Frost & Sullivan indicates that, the number of people with hyperuricemia and gout in China will continue to increase in the future, reaching 240 million and 52.2 million respectively by 2030. Currently, the commonly used uric acid-lowering drugs in clinical practice in China are those which inhibit uric acid synthesis or promote uric acid excretion. Due to certain limitations in the efficacy and safety of the marketed uric acid-lowering drugs, such as causing renal failure, sudden cardiac death or severe liver toxicity. There is still an urgent need for effective and safe uric acid-lowering drugs among gout and hyperuricemia patients in China. ABP-671 is currently with the potential to be the promising and safe product for the treatment of gout and hyperuricemia. Through this collaboration, it fills the blank in the CMS’s product portfolio of the treatment of gout. Gout and hyperuricemia are both rheumatic diseases and chronic metabolic diseases, which are highly consistent with the Group’s strategic layout in the cardio-cerebrovascular/ gastroenterology business and the network resources of marketed products. If approved for marketing in the future, the Product will synergize with the Group’s marketed product Metoject (methotrexate injection) in rheumatology and with Elcitonin (elcatonin injection) in endocrinology and orthopedics, in terms of expert network and market resources. Based on the unmet clinical needs and the expected solid clinical data of the Product, the Group is looking forward to the smooth advancement of the clinical development of ABP-671, allowing patients with relevant indications to benefit from this innovative treatment sooner. About ATOM THERAPEUTICS Atom Therapeutics was founded in March 2012, focused on the research and development of innovative drugs with global commercial value and competitiveness in the metabolic and inflammatory area. Atom Therapeutics’s main core team members come from the United States, with extensive experience in the research and development of innovative drugs. Atom Therapeutics has achieved remarkable development in the past few years. Atom Therapeutics’s core product ABP-671 is under pivotal clinical stage for the treatment of chronic gout. Atom Therapeutics’s another small molecule innovative drug named as ABP-745, used for indications in the field of anti-inflammatory immune indications. The Phase 1 clinical of ABP-745 exhibited outstanding pharmacokinetics and safety. The clinical trial is on the verge of entering Phase 2. For more information about Atom Therapeutics and its pipeline, please visit https://www.atombp.com/. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group. Reference: 1. The results of Phase 2 clinical trials was published and can be found at: https://www.atombp.com/2023/03/01/atom-bioscience-announces-positive-results-of-phase-2a-china-clinical-trial-of-its-urat1-inhibitor-for-chronic-gout/ CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

Honda Introduces AI-powered Social Robot, Haru, to University Hospital in Spain

TOKYO, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - Honda Research Institute Japan Co., Ltd. (HRI-JP), a Honda R&D subsidiary responsible for the research of cutting-edge technologies, has officially introduced its AI-powered social robot named “Haru” at the Virgen del Rocío University Hospital (HUVR) in Seville, Spain, to enhance the well-being of children while in the hospital.At the Annual Gala against Childhood Cancer, held on November 28 local time, at Casino de la Exposicion in Seville, Spain, the HUVR introduced Haru as one of the projects HUVR is implementing to improve the lives of children with cancer, who are in the hospital for long-term treatment.AI-powered social robot, HaruHRI-JP has been developing Haru, an AI-powered social robot, as a “tangible AI system” striving to realize a society where robots coexist as partners of people and to facilitate communications that create connections among people. Haru was designed to be a social robot that makes people smile through expressive communications and forms empathetic relationships with people. As a compact desk-top robot with a total height of 30cm (12 inches), Haru can be placed on a table to engage in communications with people.Haru obtains biometric information of the user, such as facial expressions and voice tones, through its built-in camera and microphones, then analyzes the information obtained to understand the user’s current state, and interacts with each user in accordance with the result of analysis, using empathetic expressions and emotionally supportive responses. Moreover, Haru can also be linked to a wristwatch-type wearable sensor worn by the user and analyze the user’s conditions in greater detail.Furthermore, as a robot, Haru does not have any human attributes such as gender, race or nationality, and is always capable of communicating from a neutral perspective, enabling Haru to effectively facilitate communication beyond generational and cultural differences, especially in group communication.HUVR had been conducting a demonstration experiment using Haru in the pediatric oncology ward of the hospital since 2021 for the purpose of enhancing both the clinical and emotional care of young patients. Since the results of the experiment have confirmed a certain level of positive effects on children with cancer, the official decision was made to advance the project with full-fledged utilization of Haru, introducing 10 units to be used in various situations in the children’s daily lives in the pediatric oncology unit.Key results of the demonstration experiment at the HUVR1. Assisting emotional and cognitive assessmentsHaru has been assisting the hospital’s neuropsychologists in conducting emotional and cognitive assessments. Using AI technology, Haru communicates with children; analyzes their biometric information, such as facial expressions and voice tones, obtained through its built-in cameras and microphones; and assist neuropsychologists in conducting emotional and cognitive assessments.Due to the amount of time the assessment takes, there is a limit to the number of assessments the neuropsychologists can conduct each year: the number had been limited to 510 per year including follow-up consultations until now. With the introduction of Haru, the number of assessments the hospital can conduct each year is expected to increase to as many as 4,500.2. Assisting rehabilitation activitiesHaru has been supporting intellectual and physical rehabilitation programs provided to young patients at the hospital. Haru learns the rehabilitation programs and can guide the children through the process while engaging them in conversation. The demonstration experiment showed that 95% of children were more actively engaged in rehabilitation while receiving guidance from Haru, compared to conventional human guides.3. Serving as a companion in playrooms and hospital roomsYoung patients who undergo long-term hospital stays for treatment spend a lot of time alone in their rooms. By communicating with the children, Haru can offer entertainment and cognitive stimulation, and help to soothe their feeling of loneliness, contributing to the enhancement of emotional care the hospital provides.4. Offering educational supportHaru connects the hospital rooms of the children who have not been able to attend school with the classrooms of their schools online, and facilitates the communication as an intermediary. This provides children at the hospital with opportunity to receive education together with children in the classroom and to interact with each other among children.Comments by the Virgen del Rocío University Hospital in Seville (HUVR)“We have been conducting joint research with HRI-JP for several years now, and gained wonderful results. We have identified that Haru holds great potential in bringing happiness to children. Typically, technologies used in hospitals focus on medical treatments or physical well-being. However, Haru has positive psychological effect of lightening the mood of our young patients and also contributes to the well-being of the hospital as a whole. The support that Haru provides, enabling children under hospital care to feel more happiness and connection with others, is unique only to Haru and offers valuable benefits not found in traditional medical care. We believe that Haru is a groundbreaking presence that creates an environment where young patients can enjoy their time here at our hospital.”Comments by Satoshi Shigemi, Honda Research Institute Japan Co., Ltd. (HRI-JP)“Based on the founding spirit of Honda, ‘using our technology to help people’ and ‘understanding people is the very essence of Honda monozukuri (art of making things),’ Honda Research Institute has been conducting research into cutting-edge technologies which have the potential to enhance positive psychological effects of people and the overall well-being of society. We are delighted by the result of our joint research with Virgen del Rocío University Hospital that shows Haru has been able to be a companion to the children at the hospital, lifting up their spirits, and bringing smiles to their faces. Moving forward, we will continue our efforts to further advance Haru as a robot which can co-exist with people 24/7 and be more helpful to young patients as well as all hospital staff to contribute to the well-being of the hospital a whole.”About Honda Research Institute (HRI)HRI was established in 2003 as a research operation which will go beyond the framework of the traditional business domain of the Honda Group and take on challenges to address issues facing humanity. Each of three HRI operations, located in Japan, the United States, and Germany, is engaged in “frontier research” with a focus on next-generation AI, including the exploration of new technologies such as quantum technology. By using Pasteur's Quadrant approach to research, which calls for the simultaneous pursuit of principles, or science, and real-world applications, HRI is striving to quickly give shape to new technologies and ideas, and create new value that can be useful to society. The research outcomes generated by HRI will lead toward the development of future Honda technologies in a wide range of technology fields, including but not limited to the areas of safety, the environment and next-generation mobility.Honda Research Institute Japan Co., Ltd. (HRI-JP), a Honda R&D subsidiary responsible for the research of cutting-edge technologies, has officially introduced its AI-powered social robot named “Haru” at the Virgen del Rocío University Hospital (HUVR) in Seville, Spain, to enhance the well-being of children while in the hospital.At the Annual Gala against Childhood Cancer, held on November 28 local time, at Casino de la Exposicion in Seville, Spain, the HUVR introduced Haru as one of the projects HUVR is implementing to improve the lives of children with cancer, who are in the hospital for long-term treatment.AI-powered social robot, HaruHRI-JP has been developing Haru, an AI-powered social robot, as a “tangible AI system” striving to realize a society where robots coexist as partners of people and to facilitate communications that create connections among people. Haru was designed to be a social robot that makes people smile through expressive communications and forms empathetic relationships with people. As a compact desk-top robot with a total height of 30cm (12 inches), Haru can be placed on a table to engage in communications with people.Haru obtains biometric information of the user, such as facial expressions and voice tones, through its built-in camera and microphones, then analyzes the information obtained to understand the user’s current state, and interacts with each user in accordance with the result of analysis, using empathetic expressions and emotionally supportive responses. Moreover, Haru can also be linked to a wristwatch-type wearable sensor worn by the user and analyze the user’s conditions in greater detail.Furthermore, as a robot, Haru does not have any human attributes such as gender, race or nationality, and is always capable of communicating from a neutral perspective, enabling Haru to effectively facilitate communication beyond generational and cultural differences, especially in group communication.HUVR had been conducting a demonstration experiment using Haru in the pediatric oncology ward of the hospital since 2021 for the purpose of enhancing both the clinical and emotional care of young patients. Since the results of the experiment have confirmed a certain level of positive effects on children with cancer, the official decision was made to advance the project with full-fledged utilization of Haru, introducing 10 units to be used in various situations in the children’s daily lives in the pediatric oncology unit.Key results of the demonstration experiment at the HUVR1. Assisting emotional and cognitive assessmentsHaru has been assisting the hospital’s neuropsychologists in conducting emotional and cognitive assessments. Using AI technology, Haru communicates with children; analyzes their biometric information, such as facial expressions and voice tones, obtained through its built-in cameras and microphones; and assist neuropsychologists in conducting emotional and cognitive assessments.Due to the amount of time the assessment takes, there is a limit to the number of assessments the neuropsychologists can conduct each year: the number had been limited to 510 per year including follow-up consultations until now. With the introduction of Haru, the number of assessments the hospital can conduct each year is expected to increase to as many as 4,500.2. Assisting rehabilitation activitiesHaru has been supporting intellectual and physical rehabilitation programs provided to young patients at the hospital. Haru learns the rehabilitation programs and can guide the children through the process while engaging them in conversation. The demonstration experiment showed that 95% of children were more actively engaged in rehabilitation while receiving guidance from Haru, compared to conventional human guides.3. Serving as a companion in playrooms and hospital roomsYoung patients who undergo long-term hospital stays for treatment spend a lot of time alone in their rooms. By communicating with the children, Haru can offer entertainment and cognitive stimulation, and help to soothe their feeling of loneliness, contributing to the enhancement of emotional care the hospital provides.4. Offering educational supportHaru connects the hospital rooms of the children who have not been able to attend school with the classrooms of their schools online, and facilitates the communication as an intermediary. This provides children at the hospital with opportunity to receive education together with children in the classroom and to interact with each other among children.Comments by the Virgen del Rocío University Hospital in Seville (HUVR)“We have been conducting joint research with HRI-JP for several years now, and gained wonderful results. We have identified that Haru holds great potential in bringing happiness to children. Typically, technologies used in hospitals focus on medical treatments or physical well-being. However, Haru has positive psychological effect of lightening the mood of our young patients and also contributes to the well-being of the hospital as a whole. The support that Haru provides, enabling children under hospital care to feel more happiness and connection with others, is unique only to Haru and offers valuable benefits not found in traditional medical care. We believe that Haru is a groundbreaking presence that creates an environment where young patients can enjoy their time here at our hospital.”Comments by Satoshi Shigemi, Honda Research Institute Japan Co., Ltd. (HRI-JP)“Based on the founding spirit of Honda, ‘using our technology to help people’ and ‘understanding people is the very essence of Honda monozukuri (art of making things),’ Honda Research Institute has been conducting research into cutting-edge technologies which have the potential to enhance positive psychological effects of people and the overall well-being of society. We are delighted by the result of our joint research with Virgen del Rocío University Hospital that shows Haru has been able to be a companion to the children at the hospital, lifting up their spirits, and bringing smiles to their faces. Moving forward, we will continue our efforts to further advance Haru as a robot which can co-exist with people 24/7 and be more helpful to young patients as well as all hospital staff to contribute to the well-being of the hospital a whole.”About Honda Research Institute (HRI)HRI was established in 2003 as a research operation which will go beyond the framework of the traditional business domain of the Honda Group and take on challenges to address issues facing humanity. Each of three HRI operations, located in Japan, the United States, and Germany, is engaged in “frontier research” with a focus on next-generation AI, including the exploration of new technologies such as quantum technology. By using Pasteur's Quadrant approach to research, which calls for the simultaneous pursuit of principles, or science, and real-world applications, HRI is striving to quickly give shape to new technologies and ideas, and create new value that can be useful to society. The research outcomes generated by HRI will lead toward the development of future Honda technologies in a wide range of technology fields, including but not limited to the areas of safety, the environment and next-generation mobility.HRI-JP has been developing Haru, an AI-powered social robot, as a “tangible AI system” striving to realize a society where robots coexist as partners of people and to facilitate communications that create connections among people. Haru was designed to be a social robot that makes people smile through expressive communications and forms empathetic relationships with people. As a compact desk-top robot with a total height of 30cm (12 inches), Haru can be placed on a table to engage in communications with people.Haru obtains biometric information of the user, such as facial expressions and voice tones, through its built-in camera and microphones, then analyzes the information obtained to understand the user’s current state, and interacts with each user in accordance with the result of analysis, using empathetic expressions and emotionally supportive responses. Moreover, Haru can also be linked to a wristwatch-type wearable sensor worn by the user and analyze the user’s conditions in greater detail.Furthermore, as a robot, Haru does not have any human attributes such as gender, race or nationality, and is always capable of communicating from a neutral perspective, enabling Haru to effectively facilitate communication beyond generational and cultural differences, especially in group communication.HUVR had been conducting a demonstration experiment using Haru in the pediatric oncology ward of the hospital since 2021 for the purpose of enhancing both the clinical and emotional care of young patients. Since the results of the experiment have confirmed a certain level of positive effects on children with cancer, the official decision was made to advance the project with full-fledged utilization of Haru, introducing 10 units to be used in various situations in the children’s daily lives in the pediatric oncology unit.Key results of the demonstration experiment at the HUVR1. Assisting emotional and cognitive assessmentsHaru has been assisting the hospital’s neuropsychologists in conducting emotional and cognitive assessments. Using AI technology, Haru communicates with children; analyzes their biometric information, such as facial expressions and voice tones, obtained through its built-in cameras and microphones; and assist neuropsychologists in conducting emotional and cognitive assessments.Due to the amount of time the assessment takes, there is a limit to the number of assessments the neuropsychologists can conduct each year: the number had been limited to 510 per year including follow-up consultations until now. With the introduction of Haru, the number of assessments the hospital can conduct each year is expected to increase to as many as 4,500.2. Assisting rehabilitation activitiesHaru has been supporting intellectual and physical rehabilitation programs provided to young patients at the hospital. Haru learns the rehabilitation programs and can guide the children through the process while engaging them in conversation. The demonstration experiment showed that 95% of children were more actively engaged in rehabilitation while receiving guidance from Haru, compared to conventional human guides.3. Serving as a companion in playrooms and hospital roomsYoung patients who undergo long-term hospital stays for treatment spend a lot of time alone in their rooms. By communicating with the children, Haru can offer entertainment and cognitive stimulation, and help to soothe their feeling of loneliness, contributing to the enhancement of emotional care the hospital provides.4. Offering educational supportHaru connects the hospital rooms of the children who have not been able to attend school with the classrooms of their schools online, and facilitates the communication as an intermediary. This provides children at the hospital with opportunity to receive education together with children in the classroom and to interact with each other among children.Comments by the Virgen del Rocío University Hospital in Seville (HUVR)“We have been conducting joint research with HRI-JP for several years now, and gained wonderful results. We have identified that Haru holds great potential in bringing happiness to children. Typically, technologies used in hospitals focus on medical treatments or physical well-being. However, Haru has positive psychological effect of lightening the mood of our young patients and also contributes to the well-being of the hospital as a whole. The support that Haru provides, enabling children under hospital care to feel more happiness and connection with others, is unique only to Haru and offers valuable benefits not found in traditional medical care. We believe that Haru is a groundbreaking presence that creates an environment where young patients can enjoy their time here at our hospital.”Comments by Satoshi Shigemi, Honda Research Institute Japan Co., Ltd. (HRI-JP)“Based on the founding spirit of Honda, ‘using our technology to help people’ and ‘understanding people is the very essence of Honda monozukuri (art of making things),’ Honda Research Institute has been conducting research into cutting-edge technologies which have the potential to enhance positive psychological effects of people and the overall well-being of society. We are delighted by the result of our joint research with Virgen del Rocío University Hospital that shows Haru has been able to be a companion to the children at the hospital, lifting up their spirits, and bringing smiles to their faces. Moving forward, we will continue our efforts to further advance Haru as a robot which can co-exist with people 24/7 and be more helpful to young patients as well as all hospital staff to contribute to the well-being of the hospital a whole.”About Honda Research Institute (HRI)HRI was established in 2003 as a research operation which will go beyond the framework of the traditional business domain of the Honda Group and take on challenges to address issues facing humanity. Each of three HRI operations, located in Japan, the United States, and Germany, is engaged in “frontier research” with a focus on next-generation AI, including the exploration of new technologies such as quantum technology. By using Pasteur's Quadrant approach to research, which calls for the simultaneous pursuit of principles, or science, and real-world applications, HRI is striving to quickly give shape to new technologies and ideas, and create new value that can be useful to society. The research outcomes generated by HRI will lead toward the development of future Honda technologies in a wide range of technology fields, including but not limited to the areas of safety, the environment and next-generation mobility. Copyright 2024 JCN Newswire via SeaPRwire.com.

DENSO to Exhibit at “Automechanika Dubai 2024”

KARIYA, JAPAN, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - DENSO Sales Middle East & North Africa (DSMN), a group company of DENSO Corporation, will participate in “Automechanika Dubai 2024,” held at the Dubai World Trade Centre from December 10 to 12, 2024.Established in 2010 in Dubai, DSMN serves the Middle East and North Africa regions by offering aftermarket products and services. In these regions, motorization is advancing, and vehicles tend to have longer operational lifespans. DSMN strives to provide customers and users with peace of mind and trust through high-quality products and services, contributing to the realization of a sustainable mobility society.Automechanika Dubai is the largest automotive aftermarket trade show in the Middle East and Africa. This year, over 2,200 exhibitors are expected to participate. Many visitors are businesses seeking to establish partnerships with exhibitors, and attendance is anticipated to exceed last year’s 52,469 visitors from 161 countries. The event offers an excellent opportunity to expand business possibilities, not only in the Middle East and Africa but also in regions such as West Asia and Central Asia.Through this exhibition, DSMN aims to showcase aftermarket solutions and explore opportunities for advanced technology-based products and services. Additionally, DSMN will deepen interactions with customers and partner companies, identifying new needs and pursuing tailored solutions to address regional challenges.Booth ImageDSMN Website: https://denso.ae/Please see here for more details on DSMN’s booth: https://denso.ae/events/join-us-at-automechanika-dubai-2024-celebrating-75-years-of-innovation Copyright 2024 JCN Newswire via SeaPRwire.com.

Fujitsu expands global strategic collaboration agreement with AWS to promote customer digital transformation across industries

KAWASAKI, Japan, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has signed a three-year global strategic collaboration agreement (SCA) with Amazon Web Services (AWS) (1). This collaboration, officially concluded on November 29, expands the existing agreements in the mobility, finance, and retail sectors to a broader range of industries .Through this collaboration, Fujitsu will combine its expertise in systems integration and its Fujitsu Uvance offering to solve societal issues with AWS’s cloud services and cloud-native architecture to accelerate customers' digital transformation (DX) and address business challenges.Additionally, with AWS’s skills training, Fujitsu aims to strengthen its delivery system by increasing the number of Fujitsu engineers who have AWS certifications from approximately 7,000 to 12,000 over the next three years and double the number of customer deals to over 800 compared to the past 3-year SCA period.BackgroundWith the target year of 2030 for achieving the United Nations Sustainable Development Goals (SDGs) approaching, Fujitsu is promoting Fujitsu Uvance, its business model that aims to increase business growth and solve societal issues.Fujitsu Uvance leverages Fujitsu's extensive technology and industry expertise to seamlessly integrate fragmented processes and data, with the aim of creating new solutions and insights for customers. To achieve this, it is crucial to move away from legacy systems and strategically utilize cloud computing with partners. By expanding strategic collaboration with AWS, the world’s most comprehensive and broadly adopted cloud, and creating a combined solution that address customers business challenges and opportunities, Fujitsu will drive digital transformation across industries.Overview of the Initiatives1. Strengthening Fujitsu’s AWS cloud migration support servicesIn addition to having customers core systems run on their mainframes and UNIX servers, which was a strategic target of the legacy modernization collaboration announced in March 2024, the two companies will strengthen migration support services for broader on-premise systems to move onto AWS. Fujitsu will provide a comprehensive set of cloud-native system integration and operation support services through Fujitsu Cloud Transformation Service and Fujitsu Cloud Managed Service (2), with technical support from AWS.2. Enhancing added value through the service integration of Fujitsu Uvance offerings and AWSFujitsu aims to enhance added value and expand the global provision of Fujitsu Uvance offerings focusing on the two pillars of Trusted Society for a prosperous and sustainable society and Digital Shifts to support customers' data-driven strategies. As part of this effort, Fujitsu has started linking the Digital Shifts offering with its Fujitsu Kozuchi AI service and Amazon Bedrock, AWS's generative AI service. For example, Fujitsu Data Intelligence Premium, an operation platform that utilizes data and AI, analyzes production line data from factories, uses AI to detect risk signs and propose countermeasures based on past cases, and converts past inspection reports into reusable structured data to visualize and share accumulated know-how in facility maintenance work within organizations. By combining business knowledge cultivated over many years with the latest technologies such as generative AI, Fujitsu will help customers improve the efficiency and the uptime of their production processes. Demonstrations of these use cases will be showcased at the Fujitsu booth during AWS re:Invent 2024 starting today in Las Vegas, US.(3)3. Reinforcing Fujitsu’s system development and delivery capabilities by increasing the number of AWS certification holdersFujitsu aims to increase the number of Fujitsu engineers who hold AWS certifications from approximately 7,000 to 12,000 over the next three years, through AWS skills training. By increasing the number of professionals who have a deep understanding of AWS cloud services, Fujitsu will accelerate the delivery of systems that realize customers' DX, doubling the number of customer deals to over 800 compared to past 3-year SCA period.Role of Fujitsu and AWS- FujitsuLeverage its customer base and system development expertise in various industries to reach enterprise and mid-market customers.Through offerings such as legacy system modernization, cloud migration and operational support, and Fujitsu Uvance, Fujitsu will support customers' DX.- AWSAWS will strengthen its technical support for Fujitsu with its solution architects and provide advisories on the use of latest AWS services such as generative AI and cloud-native architectures for diverse use cases. AWS will also provide development environments to review latest AWS services, while also offering funds for joint sales and marketing, and AWS training and certifications for Fujitsu engineers.Yoshinami Takahashi, Vice President and COO for Uvance, Fujitsu Limited comments:“We are pleased to have concluded this global strategic collaboration with AWS. By extending our strategic collaboration to a broader range of industries, we will contribute to the digital transformation of customers across industries through legacy modernization, cloud lift and shift, and the utilization of technology and data offerings from Fujitsu Uvance together with AWS."Jaime Vallés, Vice President, Asia Pacific and Japan, Amazon Web Services comments:"Since 2012, AWS and Fujitsu have supported the digital transformation of customers in the mobility, finance, and retail sectors in Japan and worldwide. Today, we are delighted to expand our strategic collaboration with Fujitsu. Together we will broaden our Digital Transformation Experience to enable a wider range of industries and leverage our shared culture of innovation to jointly address some of the world’s biggest challenges."(1) Amazon Web Services: Headquartered in Seattle, Washington, USA, CEO Matt Garman. The collaboration was concluded with Amazon Web Services Japan GK (Head Office: Shinagawa-ku, Tokyo; President: Akihiko Shirahata).(2) Fujitsu Cloud Transformation Service and Fujitsu Cloud Managed Service: Based on Fujitsu's system design, construction, and operation know-how cultivated mainly in the enterprise domain, these services realize standardization and automation of architecture patterns, ensuring high quality while achieving cost-optimized and rapid delivery. Fujitsu adopts the "AWS Well-Architected Framework" in its delivery services, which is optimized for AWS, and has obtained the "AWS Managed Service Provider (MSP)" certification, proving the soundness and high technical capability of its AWS business.(3) AWS re:Invent: AWS’s annual global conference that starts from December 2, 2024 in Las Vegas. For more information on AWS re:Invent, please visit: https://reinvent.awsevents.com/About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.

康哲药业获得治疗痛风及高尿酸血症的1类新药独家商业化权利

深圳, 2024年12月2日 - (亚太商讯 via SeaPRwire.com) - 康哲药业控股有限公司(以下简称"康哲药业")欣然宣布,于2024年12月2日,通过其全资附属公司与杭州新元素药业有限公司(以下称"新元素药业",曾用名"江苏新元素医药科技有限公司")就治疗痛风及高尿酸血症的1类新药ABP-671("产品")签订独家商业化协议("协议")。根据协议,康哲药业获得产品在中国大陆、香港特别行政区及澳门特别行政区的独家商业化权利。合作期限开始于协议生效之日,自产品首次在中国大陆获批上市起拥有十年的授权期限("授权期限")。授权期限届满后,根据协议约定的特定条件,授权期限可自动续期十年。ABP-671是用于治疗痛风及高尿酸血症的化药1类创新药,目前正分别在中国和境外开展关于痛风的2b/3期临床试验,产品通过抑制尿酸盐转运蛋白1(URAT1),降低肾脏对尿酸的重吸收。在已经完成的两项2期临床试验结果显示,ABP-671多个剂量组(1mg至12mg)表现出良好的药效和安全性。该产品2mg每天单次给药,其药效可能相当于或优于苯溴马隆和非布司他最高剂量80mg的药效。尿酸下降可维持全天候24小时,没有出现严重的安全性问题。产品有望为痛风及高尿酸血症患者带来疗效更优、安全性更高的治疗选择[1]。与ABP-671相关的化合物和用途方面的多个专利已在中国获得授权。高尿酸血症是指成人在正常嘌呤饮食情况下,非同日2次空腹血尿酸水平超过420μmol/L (7.0mg/dL)。高尿酸血症患者出现尿酸盐晶体沉积,导致痛风性关节炎,称为痛风。高尿酸血症及痛风可引起关节软骨、骨质、肾脏以及血管壁等急慢性炎症损伤,导致心、脑、肾等多器官损害。《2021中国高尿酸及痛风趋势白皮书》数据显示,我国高尿酸血症的总体的患病率为13.3%,高尿酸血症患病人数约1.77亿人,痛风总体发病率为1.1%,患病人数约为1,466万。据弗若斯特沙利文分析,未来中国高尿酸血症和痛风患病人数会持续增加,将在2030年分别达到2.4亿人、5,220万人。目前我国临床上常用的降尿酸药物主要包括抑制尿酸合成和促进尿酸排泄两类,由于已上市降尿酸药物在疗效和安全性上仍存在一定的局限性,如导致肾衰竭、心脏猝死或严重肝脏毒性等。中国痛风及高尿酸血症患者对高效安全的降尿酸药物仍然有迫切的需求。ABP-671是当前痛风及高尿酸血症治疗中潜在疗效优、安全性好的产品。通过本次合作引进,填补了康哲药业痛风治疗产品的空白。痛风及高尿酸血症既属于风湿疾病又属于慢性代谢性疾病,与康哲药业心脑血管/消化业务的战略布局,以及在售品种的网络资源高度契合。ABP-671如未来获批上市,在风湿免疫科可与在售产品美泰彤(甲氨蝶呤注射液),在内分泌科和骨科可与益盖宁(依降钙素注射液)在专家网络与市场资源方面协同。基于未满足的临床需求和产品预期扎实的临床数据,期待ABP-671的临床开发工作顺利推进,使相关适应症患者尽快从创新疗法中获益。关于新元素药业新元素药业创办于2012年3月,专注于代谢和炎症领域疾病中具有全球商业价值和全球竞争力的创新药的研发。新元素药业主要核心团队人员来自美国,具有广泛的创新药物的研发经验,过去几年新元素药业取得了显著的发展成果。其核心产品ABP-671正处于后期临床研发阶段,用于治疗慢性痛风;另一个小分子创新药物ABP-745用于抗炎自免领域适应症,已完成1期临床,表现出良好的PK和安全性,即将进入2期临床。有关新元素药业及其产品的更多信息,请访问其官方网站:https://www.atombp.com/。关于康哲药业康哲药业是一家链接医药创新与商业化,把控产品全生命周期管理的开放式平台型企业,致力于提供有竞争力的产品和服务,满足尚未满足的医疗需求。康哲药业专注于全球首创(FIC)及同类最优(BIC)的创新产品,并高效推进创新产品临床研究开发和商业化进程,赋能科研成果向诊疗实践的持续转化,造福患者。康哲药业聚焦专科领域,拥有被验证的商业化能力,广泛的渠道覆盖和多疾病领域专家资源,核心在售产品已获领先的学术与市场地位。康哲药业围绕优势专科领域不断纵深发展,以巩固心脑血管/消化业务竞争力,并将皮肤医美、眼科业务独立运营,培育专科小领域的大龙头,提升专科规模效率。同时业务版图拓展至东南亚市场,着力成为全球药企进军东南亚市场的"桥头堡",助力康哲药业高质量持续健康发展。参考文献:1.产品2期临床试验结果已发布,详情如下:https://www.atombp.com/2023/03/01/atom-bioscience-announces-positive-results-of-phase-2a-china-clinical-trial-of-its-urat1-inhibitor-for-chronic-gout/康哲药业免责与前瞻性声明本新闻无意向您做任何产品的推广,非广告用途。本新闻不对任何药品和医疗器械和/或适应症作推荐。若您想了解具体疾病诊疗信息,请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何与治疗有关的决定应根据患者的具体情况并遵照药品说明书。由康哲药业编制的此新闻不构成购买或认购任何证券的任何要约或邀请,不形成任何合约或任何其他约束性承诺的依据或加以依赖。本新闻由康哲药业根据其认为可靠之资料及数据编制,但康哲药业并无进行任何说明或保证、明述或暗示,或其他表述,对本新闻内容的真实性、准确性、完整性、公平性及合理性不应加以依赖。本新闻中讨论的若干事宜可能包含涉及康哲药业的市场机会及业务前景的陈述,该等陈述分别或统称为前瞻性声明。该等前瞻性声明并非对未来表现的保证,存在已知及未知的风险、不明朗性及难以预知的假设。康哲药业并不采纳本新闻包含的第三方所做的任何前瞻性声明及预测,康哲药业对该等第三方声明及预测不承担责任。 Copyright 2024 亚太商讯 via SeaPRwire.com.

eBRAM Partners with Agency for Volunteer Service to Launch ‘Pro-Bono Online Mediation Scheme for Water Seepage Disputes’

HONG KONG,Dec 3, 2024 - (ACN Newswire via SeaPRwire.com) - In order to resolve conflicts and disputes between property owners and occupants in Hong Kong caused by water seepage issues, eBRAM International Online Dispute Resolution Centre (“eBRAM”), an independent non-profit arbitration and mediation organisation, today joined hands with the Agency for Volunteer Service to officially launch the Pro-bono Online Mediation Scheme for Water Seepage Disputes (“Scheme”). The Scheme is free of charge and aims to foster a harmonious community by providing the public with efficient and economical online mediation services to help resolve water seepage disputes in the community.The Scheme has received strong support from the “Joint Office” set up by the Food and Environmental Hygiene Department and the Buildings Department. When water seepage issues arise, both parties involved can agree to conduct mediation at any stage. The parties can do so by submitting a request through eBRAM’s platform under the Scheme. The platform will then arrange for independent and neutral volunteer mediators to mediate the parties’ dispute. The Scheme aims to enable parties to resolve disputes in the simplest, most cost-effective, and time-efficient manner.Actively Assumes Social Responsibility and Alleviates the Concerns and Difficulties of the CitizensThe issue of building leakage or water seepage is a common source of dispute in the Hong Kong community, and multi-faceted issue encompasses cost split and responsibility for carrying out repairs . This issue has been troubling property owners and occupants in Hong Kong, as it is complicated and involves multiple parties’ responsibilities. Traditional legal proceedings are time-consuming and expensive, making it difficult to resolve these issues in a short period of time, which often causes great suffering to the residents involved.In view of this, as a leading non-profit arbitration and mediation organisation in Hong Kong, eBRAM actively uses innovative approaches to address social livelihood issues. Launched in cooperation with the Agency for Volunteer Service and supported by the Food and Environmental Hygiene Department and the Buildings Department, this free online mediation service fills a gap in legal services and provides an efficient, economical and convenient solution for members of the public who are in need.Efficiently Resolves Water Seepage Disputes, Highlights Advantages of Online MediationeBRAM’s mediation rules and online dispute resolution platform have overcome the time and space limitations of traditional mediation, allowing parties to participate in mediation process anytime and anywhere. Compared with cumbersome litigation procedures, online mediation is fast and efficient, and lowers the threshold for resolving disputes so that both parties do not have to go through lengthy legal proceedings and pay expensive litigation fees. This flexible service model meets the needs of the busy public living in modern cities to build a harmonious community.In addition, mediation is led by the parties involved, who have more control over the outcome. Both parties can work together to agree on a solution, rather than leaving the decision-making process entirely to the court. At the same time, mediation emphasizes fairness and understanding, which aims to reduce tensions between the parties, avoids escalation of conflicts, and protects their neighbourhood relations. As a third party, professional mediators maintain a neutral stance and assist the parties in discussing feasible solutions that give them peace of mind.Innovative LawTech to Help Build a Harmonious FutureDr Thomas So, JP, Chairman of eBRAM, said, "We are committed to serving our society, promoting sustainable development, and giving back to the community by leveraging innovative technologies and applying our expertise. By collaborating with the Agency for Volunteer Service and with the support of the Food and Environmental Hygiene Department and the Buildings Department, the launch of the free ‘Pro-bono Online Mediation Scheme for Water Seepage Disputes’ has not only helped solve the public’s livelihood issues, but also provided new ideas for building a harmonious and inclusive social environment. Looking ahead, we will continue to work closely with the government and other organisations to provide high-quality and efficient dispute resolution services to more members of the public."Ms. Melissa Pang, BBS, MH, JP, Chairman of the Agency for Volunteer Service, said, "We have always been attentive to the needs of the members of the public and are committed to playing a pivotal role in collaborating with various sectors of society to address livelihood issues. By having dedicated professional mediators who are passionate about serving society as volunteer workers, we provide free mediation services to relevant owners and occupants through eBRAM’s online platform, believing that we can play a crucial role in resolving building leakage disputes within the community. We look forward to promoting community harmony through this innovative initiative, ensuring that members of the public can live and work in peace."According to the figures released by the Joint Office, over the past five years, there have been an average of over 40,000 complaints per year on water seepage issues. The number of cases in which the source of water seepage was identified and relevant investigations completed averaged around 5,800 cases per year, accounting for approximately 14.5% of the total number of complaints. As at September 2023, the number of cases under investigation was around 10,000. Between 2020 and 2022, investigation on approximately 30% of the cases could not be completed and complainants were not informed of the investigation results within 90 working days. The “Pro-bono Online Mediation Scheme for Water Seepage Disputes” initiated by eBRAM and the Agency for Volunteer Service is set to effectively reduce the time required to handle water seepage cases, increase efficiency in addressing the public’s livelihood issues, and play a more active role in promoting harmony in the community and reducing social conflicts.“Pro-bono Online Mediation Scheme for Water Seepage Disputes” Webpage:https://ebram.org/Water_Seepage_POM_Scheme/?language=en Copyright 2024 ACN Newswire via SeaPRwire.com.

联康集团获批重组胶原蛋白II类医疗器械 推出首款进军高增长医疗美容市场的上市产品——肌颜态®

EQS 新闻 via SEAPRWire.com / 2024-12-02 / 18:14 UTC+8        2024年12月02日–联康生物科技集团有限公司(简称“联康集团”或“本集团”)欣然宣布两项重要里程碑,展现了联康集团在医疗美容和皮肤解决方案领域的持续增长和创新突破。 本集团与重庆民济医疗器械有限公司的战略合作产品——医用重组胶原蛋白敷料,已成功获批二类医疗器械注册证,注册证编号为「渝械注准 20242140377」。与此同时,本集团自主研发的纤连蛋白医疗美容产品——肌颜态®也重磅上市,并在武汉举办了盛大的产品发布会。众多行业专家、意见领袖、媒体代表和其他专业人士齐聚一堂,共同见证了联康集团进军快速增长、千亿规模的医疗美容市场。这一里程碑标志着在此高潜力领域,本集团掀开持续扩大自身影响力的新篇章。 (图:肌颜态®上市发布会大合影) 胶原蛋白作为新获批的医用重组胶原蛋白敷料的核心成分,是人体内最丰富的蛋白质,占全身蛋白质含量的25%至35%。它通过形成一个弹性纤维网络,支撑皮肤,保持弹性并锁住水分。胶原蛋白的含量在人成熟后(约21岁)每年减少约1%,导致皮肤的紧致度及弹性下降。胶原蛋白产品可广泛用于保湿、维持皮肤屏障及抗衰老。除了敷料剂型外,胶原蛋白的微针也正在研发进程中。       另一个扩充产品组合的重要里程碑,是基于本集团的专利原料——SkbrellaTM FN(重组人源纤连蛋白)自主研发的医疗美容品牌——肌颜态®的重磅上市。肌颜态®旨在提供安全有效的皮肤护理解决方案,以修复和改善皮肤质量,是修复受损皮肤、敏感皮肤以及医美术后护理的理想选择。纤连蛋白是皮肤细胞外基质重要组成部分,在细胞迁移、粘附、增殖、止血及组织修复中起着至关重要的作用。本集团也正在推进基于纤连蛋白成分的医疗器械的研发。 (图左:肌颜态®纤连蛋白修复液;图右:肌颜态®纤连蛋白精华液) 肌颜态®的首次亮相便吸引了众多皮肤科专家及医美从业者的高度认可及关注。发布会上,各位专家学者从不同的视角,针对纤连蛋白的作用功效和临床使用进行了专业的学术交流和案例分享:“肌颜态®是可以贯穿医美术前、术后全周期使用的具有显著功效的产品,尤其是对于麻药过敏患者,可以实现迅速修复和有效褪红。” (图:南方医科大学广东省皮肤病医院院长杨斌教授分享皮肤科临床实践) (图:中山大学附属第六医院整形科主任施歌教授分享肌颜态®使用案例)         联康集团CEO赵志刚先生也表示:“本集团依托于金因肽®在皮肤领域接近30年的可靠临床数据、皮肤科领域的专业知识及已经建立的营销网络,秉承药企严谨的研发标准,构建‘生物药+医疗器械+医疗美容’的多元化产品组合,最终为广大患者提供更安全、更有效的全周期皮肤护理解决方案。” (图左:联康集团CEO赵志刚先生为肌颜态®上市致开幕词;图右:联康集团研发及项目副总监于珊博士介绍肌颜态®) 本集团将会充分抓住不断增长的市场机会以占据优势地位。预测显示,医疗美容市场将于二零二四年至二零二七年间保持10%至15%的复合年增长率,2030年将有望超过6000亿元人民币。胶原蛋白医疗器械的获批和肌颜态®的上市预示着联康集团在皮肤护理领域开启新征程。 (图:联康集团董事长梁国龙先生成功与多家知名医疗美容连锁机构及分销渠道商建立合作关系) 这些成就反映了集团对创新、战略执行和价值创造的坚定承诺。随着集团继续执行战略愿景,致力于成为中国皮肤科的领先专家的目标,利用创新能力、临床专业知识以及市场洞察力,从而推动可持续增长和长期成功。 End 2024-12-02 此财经新闻稿由EQS Group via SEAPRWire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

15 Companies Pitch Their Capabilities at GA-ASI’s Blue Magic Netherlands

SAN DIEGO, CA, Dec 3, 2024 - (ACN Newswire via SeaPRwire.com) - On November 19, 2024, General Atomics Aeronautical Systems, Inc. (GA-ASI) hosted its first Blue Magic Netherlands (BMN) event in Eindhoven, the Netherlands. Approximately 200 people attended the event that provided Dutch businesses with an opportunity to present their capabilities to GA-ASI and other companies interested in possible collaborations. GA-ASI was joined for the event by the Netherlands Ministry of Economic Affairs, the Netherlands Ministry of Defence, Lockheed Martin Ventures, Brainport Development, Brabant Development Agency (BOM), the Netherlands Industries for Defence & Security (NIDV), and SpaceNED.At this event, GA-ASI and its partners heard first-hand from Dutch companies about the important capabilities they are developing. The process started in July when GA-ASI put out an open invitation to Dutch businesses to apply for the opportunity to present innovative technologies at the November 19 event. Key areas of focus included Artificial Intelligence/Machine Learning, Autonomy, Advanced Materials, Sensors, Advanced Manufacturing, and Space. Close to 50 companies applied and after reviewing the applications, 15 businesses were selected to pitch their capabilities to an audience that included lightweight lattice structures, gas detection technologies, advanced battery and photonics applications, and several innovative unmanned system and AI applications, among many others."This event is where the rubber meets the road," said Brad Lunn, Managing Director-Strategic Finance at GA-ASI. "In addition to attracting many companies, we increased the areas of expertise and depth of knowledge from the presenting companies in order to provide research, development, and breakthrough innovations to support current and future missions by GA-ASI aircraft. We also wanted to give the companies an opportunity to pitch in front of other potential customers, partners, and investors."The first Blue Magic event held by GA-ASI was in 2019 in Belgium, with subsequent events held in 2020, 2021, and 2023. GA-ASI is delivering eight MQ-9A Remotely Piloted Aircraft to the Royal Netherlands Air Force (RNLAF).GA-ASI expects to announce technology partnerships stemming from the BMN event and intends to hold this event on an annual basis in the Netherlands.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable remotely piloted aircraft (RPA) systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent flight that enables situational awareness and rapid strike. The company also produces a variety of ground control stations and sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas. For more information, visit www.ga-asi.com.Avenger, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.comSource: General Atomics Aeronautical Systems, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.